If you hear the expression E.R. being tossed around in medical circles this week, don't assume that everyone is talking about emergency rooms -- or the hit hospital drama on NBC.
No, it's E.R. as in earnings report, as a bevy of pharmaceutical and biotechnology giants are set to disclose the numbers behind their September quarters.
Tomorrow, it's biotech biggie Amgen
Wednesday will be a huge day for the pharmaceuticals as Pfizer
Keep that in mind the next time you need an excuse to call in sick to work. As for the drug stocks in general? Let's hope they're not the ones calling in sick this week.Do you think Amgen's earnings report will help biotech recover from MedImmune's bad Wal-Mart news on Friday? What about Amgen's new anemia drug? Is it another blockbuster? All this and more -- in the Amgen discussion board. Only on Fool.com.